These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 31060800)

  • 41.
    Le Run E; Arthur M; Mainardi JL
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745387
    [No Abstract]   [Full Text] [Related]  

  • 42. Mycobacterium bolletii Lung Disease in Cystic Fibrosis.
    Rollet-Cohen V; Roux AL; Le Bourgeois M; Sapriel G; El Bahri M; Jais JP; Heym B; Mougari F; Raskine L; Véziris N; Gaillard JL; Sermet-Gaudelus I
    Chest; 2019 Aug; 156(2):247-254. PubMed ID: 30935892
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Meropenem versus imipenem/cilastatin in the treatment of hospitalized patients with skin and soft tissue infections.
    Nichols RL; Smith JW; Geckler RW; Wilson SE
    South Med J; 1995 Apr; 88(4):397-404. PubMed ID: 7716590
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Meropenem versus imipenem/cilastatin in the treatment of intra-abdominal infections.
    Brismar B; Malmborg AS; Tunevall G; Lindgren V; Bergman L; Mentzing LO; Nyström PO; Anséhn S; Bäckstrand B; Skau T
    J Antimicrob Chemother; 1995 Jan; 35(1):139-48. PubMed ID: 7768761
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Imipenem-cilastatin vs. tobramycin and metronidazole for appendicitis-related infections.
    Uhari M; Seppänen J; Heikkinen E
    Pediatr Infect Dis J; 1992 Jun; 11(6):445-50. PubMed ID: 1608680
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Radiologic computed tomography features of Mycobacterium abscessus in cystic fibrosis.
    Lam DL; Kapnadak SG; Godwin JD; Kicska GA; Aitken ML; Pipavath SN
    Clin Respir J; 2018 Feb; 12(2):459-466. PubMed ID: 27460837
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antimycobacterial activity of nonantibiotics associated with the polypharmacy of cystic fibrosis (CF) against mycobacterium abscessus.
    Kirkwood ZI; Millar BC; Downey DG; Moore JE
    Int J Mycobacteriol; 2018; 7(4):358-360. PubMed ID: 30531035
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis.
    Ryan G; Jahnke N; Remmington T
    Cochrane Database Syst Rev; 2012 Dec; 12():CD008319. PubMed ID: 23235659
    [TBL] [Abstract][Full Text] [Related]  

  • 49.
    Beech AJ; Weinberg SE; Mortimer AE; Lynch F; Bedford J; Calisti G
    J Clin Tuberc Other Mycobact Dis; 2023 Aug; 32():100381. PubMed ID: 37323244
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of tularemia with imipenem/cilastatin sodium.
    Lee HC; Horowitz E; Linder W
    South Med J; 1991 Oct; 84(10):1277-8. PubMed ID: 1925735
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Dosage of imipenem/cilastatin].
    Shah PM
    Infection; 1986; 14 Suppl 2():S143-7. PubMed ID: 3759249
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Compassionate Nitric Oxide Adjuvant Treatment of Persistent Mycobacterium Infection in Cystic Fibrosis Patients.
    Yaacoby-Bianu K; Gur M; Toukan Y; Nir V; Hakim F; Geffen Y; Bentur L
    Pediatr Infect Dis J; 2018 Apr; 37(4):336-338. PubMed ID: 28885458
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of nosocomial infections in children undergoing antimicrobial chemotherapy.
    Bonatti H; Guggenbichler JP; Hager J
    Infection; 1990; 18(5):302-6. PubMed ID: 2276826
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of imipenem/cilastatin with the combination of aztreonam and clindamycin in the treatment of intra-abdominal infections.
    de Groot HG; Hustinx PA; Lampe AS; Oosterwijk WM
    J Antimicrob Chemother; 1993 Sep; 32(3):491-500. PubMed ID: 8262872
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lung transplantation in patients with cystic fibrosis and Mycobacterium abscessus infection.
    Gilljam M; Scherstén H; Silverborn M; Jönsson B; Ericsson Hollsing A
    J Cyst Fibros; 2010 Jul; 9(4):272-6. PubMed ID: 20400381
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Clinical experience with imipenem/cilastatin in the treatment of severe infections in general surgery].
    Mayer M; Brand J; Schlenkhoff D; Opferkuch W
    Infection; 1986; 14 Suppl 2():S160-3. PubMed ID: 3079549
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Levofloxacin in the empirical treatment of patients with suspected bacteraemia/sepsis: comparison with imipenem/cilastatin in an open, randomized trial.
    Geddes A; Thaler M; Schonwald S; Härkönen M; Jacobs F; Nowotny I
    J Antimicrob Chemother; 1999 Dec; 44(6):799-810. PubMed ID: 10590282
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Factors predisposing to seizures in seriously ill infected patients receiving antibiotics: experience with imipenem/cilastatin.
    Calandra G; Lydick E; Carrigan J; Weiss L; Guess H
    Am J Med; 1988 May; 84(5):911-8. PubMed ID: 3284342
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Imipenem/cilastatin treatment of bacterial meningitis in children.
    Wong VK; Wright HT; Ross LA; Mason WH; Inderlied CB; Kim KS
    Pediatr Infect Dis J; 1991 Feb; 10(2):122-5. PubMed ID: 2062603
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetics in healthy subjects of FCE 22101 and its acetoxymethyl ester, FCE 22891: effect of co-administration of imipenem/cilastatin on the renal metabolism of FCE 22101.
    Norrby SR; Burman LA; Sassella D; Corigli R; Cassinelli G; Franceschi G; Dornbusch K
    J Antimicrob Chemother; 1990 Mar; 25(3):371-83. PubMed ID: 2338416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.